A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Center for Applied Technology Development Bookmark and Share

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Center for Applied Technology Development Staff

Center for Applied Technology Development

Sylvia R. and Isador A. Deutch Center for Applied Technology Development

City of Hope conducts basic research that produces valuable intellectual property, which is translated into new products, new businesses and new jobs.
 
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs. It also fosters commercial investment in the development of inventions and discoveries derived from research at City of Hope by licensing the relevant intellectual property. Through evaluation, marketing and licensing processes, CATD supports this goal by ensuring that technologies created at City of Hope are developed and commercialized for the benefit of the widest possible audience.
 
Among its many activities, CATD also hosts conferences for venture capitalists, at which City of Hope investigators present their findings to potential funding sources.
 
Our Office of Technology Licensing (OTL) actively pursues patent protection for new inventions devised by its investigators deemed of commercial importance. Further, the OTL licenses intellectual property (IP) via Internet marketing, targeted marketing and inquiries by outside interested parties.
 
The Center for Biomedicine & Genetics (CBG) is a premier academic facility specializing in rapid production of pharmaceutical-grade materials. CBG invites collaborators from other institutions and biopharmaceutical companies to test promising new therapeutics, and supports phase I and II clinical trials at City of Hope.
 
The Office of IND Development and Regulatory Affairs helps campus investigators interact with governmental regulatory agencies and remain in compliance with United States Food and Drug Administration requirements.
 
City of Hope is a designated Production Assistance for Cellular Therapies (PACT) facility. For additional information about this program, click on the link: www.pactgroup.net/
 
Partners and Contributors
City of Hope is deeply grateful to our partners whose contributions have made the  Center for Biomedicine & Genetics possible. In particular, we would like to thank the National Office Products Industry . In recognition of their generous gift to Center for Biomedicine and Genetics (CBG), the first floor of the CBG facility is named the Sylvia R. and Isador A. Deutch Center for Applied Technology Development.
 

Meet Our Staff

Center for Applied Technology Development Staff

Contact Us
For inquiries concerning the CBG manufacturing facility and collaborative opportunities please contact:
 
Larry A. Couture, Ph.D. or
David Hsu, Ph.D.
Center for Applied Technology Development
City of Hope
1500 E. Duarte Road
Duarte, CA 91010
626-256-8728
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • It was 2009 when a City of Hope patient in her 40s learned that the cancer she had been fighting for several years had metastasized to her lungs. Her medical team ran genetic tests on the tumor, but none of the drug therapies available at the time targeted the known mutations in the tumor cells. […]
  • Acute myeloid leukemia (AML) is characterized by a rapidly-developing cancer in the myeloid line of blood cells, which is responsible for producing red blood cells, platelets and several types of white blood cells called granulocytes. Because AML grows rapidly, it can quickly crowd out normal blood cells, leadi...
  • Rachel Divine is a yoga therapist and patient leader for the Sheri & Les Biller Patient and Family Resource Center. She’s also a former City of Hope patient. When someone you know has cancer, even the word “cancer” can make you feel nervous, sleepless, depressed or more. But, as a yoga teacher for 15 ...
  •   Diagnosed with type 1 diabetes when she was 9 years old, Gina Marchini accepted the fact that she would need insulin the rest of her life. Every day, she injected herself with the lifesaving hormone. She also carefully controlled her diet and monitored the rise and fall of her blood glucose with military...
  • The defeat of cancer will require a team effort. Nowhere is this more necessary (or apparent) than in efforts to combat two of the most deadly forms of the disease  – pancreatic cancer and triple-negative breast cancer. It’s the approach City of Hope is taking with its newly launched multidisciplinary teams, br...
  • It’s a reasonable question: Why is the National Cancer Institute funding a study on preventing heart failure? The answer is reasonable as well: Rates of heart failure are drastically high among childhood cancer survivors — 15 times higher than among people the same age who were never treated for cancer. T...
  • Many teenagers take a break from academics during the summer, but not the eight high school students enrolled in the California Institute for Regenerative Medicine (CIRM) Creativity Awards program at City of Hope. They took the opportunity to obtain as much hands-on research experience as possible, learning fro...
  • About one in eight women will develop breast cancer at some point in her life. In fact, breast cancer is the most common cancer in American women, behind skin cancer. Although women can’t change some risk factors, such as genetics and the natural aging process, there are certain things they can do to lower thei...
  • As genetic testing becomes more sophisticated, doctors and their patients are finding that such tests can lead to the discovery of previously unknown cancer risks. In his practice at City of Hope, Thomas Slavin, M.D., an assistant clinical professor in the Division of Clinical Cancer Genetics, sees the full spe...
  • And the winners are … everyone in the San Gabriel Valley. The recipients of City of Hope’s first-ever Healthy Living grants have been announced, and the future is looking healthier already. In selecting San Gabriel Valley organizations to receive the grants, City of Hope’s Community Benefits Advisory Council ch...
  • Barry Leshowitz is a former City of Hope patient and a family advisor for the Sheri & Les Biller Patient and Family Resource Center. It’s been almost seven years since I checked into a local hospital in Phoenix for a hip replacement, only to be informed by the surgeon that he had canceled the surgery....
  • When it comes to science, the best graduate schools don’t just train scientists, they prepare their students for a lifetime of learning, accomplishment and positive impact on society. At City of Hope, the Irell & Manella Graduate School of Biological Sciences goes one step further – by preparing students to...
  • Cancer affects not just the cancer patient, but everyone around him or her, even after treatment is complete. The challenges can include the fear of cancer recurrence, coping with cancer’s economic impact and the struggle to achieve work-life balance post-treatment. Family members and loved ones of cancer patie...
  •   Bladder cancer facts: Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. 2015 estimates: 74,000 new cases of bladder cancer diagnosed 16,000 deaths from bladder cancer (about 11,510 in men and 4,490 in women) Risk factors for bladder cancer: Smoking: Smokers...
  • Women with ovarian cancer have questions about the most promising treatment options, revolutionary research avenues, survivorship and, of course, the potential impact on their personal lives. Now, together in one place, are experts who can provide answers. On Saturday, Sept. 12, the 2015 Ovarian Cancer Survivor...